Table 2 Patients of grade II and above characteristics
Number of patients | 227 |
|---|---|
Age (mean ± SD), years | 27.0 ± 14.5 |
Women, n (%) | 104 (45.8%) |
Grade, n (%) | |
II | 107 (47.1%) |
III | 73 (32.2%) |
IV | 47 (20.7%) |
Primary diseases, n (%) | |
Acute myeloid leukemia | 53 (23.3%) |
Myelodysplastic syndrome | 25 (11.0%) |
Acute lymphoblastic leukemia | 91 (40.1%) |
Acute mixed cell leukemia | 6 (2.6%) |
Hodgkin's lymphoma | 3 (1.3%) |
Aplastic anemia | 32 (14.1%) |
T-cell lymphoma | 1 (0.4%) |
Others | 16 (7.0%) |
CMV virus positivity, n (%) | 84(37.0%) |
EB virus positivity, n (%) | 35(16.3%) |
Cyclophosphamide exposure, n (%) | 201(88.5%) |
CBI failure | 39(17.2%) |